Monday, 19 August 2019

AstraZeneca's Farxiga meets main goal of heart failure study

British drugmaker AstraZeneca Plc said on Tuesday that its diabetes drug Farxiga met the main goal of a late-stage study for the treatment of patients with heart failure.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)